Patents by Inventor Ulrich R. Hengge

Ulrich R. Hengge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment for cutaneous metastases
    Patent number: 8461174
    Abstract: The present invention provides methods for treating cutaneous metastases. In one aspect, the method can include identifying a treatment area that comprises one or more lesions containing metastatic cells; and administering an IRM compound to the treatment area in an amount effective for treating the lesion. In another aspect, the method can include identifying a treatment area that comprises one or more lesions containing metastatic cells; and administering a TLR7 agonist to the treatment area in an amount effective for treating the lesion. In another aspect, the method can include identifying a treatment area that comprises one or more lesions containing metastatic cells; and administering a TLR8 agonist to the treatment area in an amount effective for treating the lesion.
    Type: Grant
    Filed: December 30, 2005
    Date of Patent: June 11, 2013
    Assignee: 3M Innovative Properties Company
    Inventors: Bernd Benninghoff, Ulrich R Hengge
  • TREATMENT FOR CUTANEOUS METASTASES
    Publication number: 20100056557
    Abstract: The present invention provides methods for treating cutaneous metastases. In one aspect, the method can include identifying a treatment area that comprises one or more lesions containing metastatic cells; and administering an IRM compound to the treatment area in an amount effective for treating the lesion. In another aspect, the method can include identifying a treatment area that comprises one or more lesions containing metastatic cells; and administering a TLR7 agonist to the treatment area in an amount effective for treating the lesion. In another aspect, the method can include identifying a treatment area that comprises one or more lesions containing metastatic cells; and administering a TLR8 agonist to the treatment area in an amount effective for treating the lesion.
    Type: Application
    Filed: December 30, 2005
    Publication date: March 4, 2010
    Inventors: Bernd Benninghoff, Ulrich R. Hengge